News | September 14, 2009

Initial Clinical Experience With LipiScan Spectroscopy Highlighted at TCT 2009

September 14, 2009 – InfraReDx said it will highlight its LipiScan Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept. 21-25 in San Francisco.

The LipiScan will be displayed in the emerging technologies section at booth 2410. InfraReDx events at TCT 2009 include:

• At 2:40 p.m. Monday, Sept. 21, in room 130 at the Moscone Center, James Muller, M.D., founder and CEO of InfraReDx, will speak on "Vulnerable Plaque: Emerging Directions for Diagnosis and Treatment: Near Infrared Spectroscopy I: Technology and validation."

• The company will host a breakfast symposium, "Beyond Angiography: NIR Spectroscopy and Other Methods for Plaque Characterization," Friday, Sept. 25, in room 120 at the Moscone Center. The breakfast starts at 6:30 a.m. and the session begins at 7 a.m. Presenters include Cindy Grines, M.D., Beaumont Hospital; Gregg W. Stone, M.D., Presbyterian/Columbia; Emmanouil Brilakis, M.D., Dallas
VA; Brijeshwar Maini, M.D., Moffitt Heart and Vascular; Patrick Serruys, M.D., Erasmus Medical Center; and James E. Muller, M.D., InfraReDx.

For more information: www.infraredx.com

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
CDN to Integrate Advanced Cardiac Imaging Tools From DiA Imaging Analysis
Technology | August 10, 2017
August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-g
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Overlay Init